OBSL1
protein-codingobscurin like cytoskeletal adaptor 1, the group of I-set domain containing
Gene summary
Cytoskeletal adaptor proteins function in linking the internal cytoskeleton of cells to the cell membrane. This gene encodes a cytoskeletal adaptor protein, which is a member of the Unc-89/obscurin family. The protein contains multiple N- and C-terminal immunoglobulin (Ig)-like domains and a central fibronectin type 3 domain. Mutations in this gene cause 3M syndrome type 2. Alternatively spliced transcript variants encoding different isoforms have been found in this gene. [provided by RefSeq, Mar 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~21.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013039
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013039
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0007477
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013039
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013039
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Endocrine; Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to OBSL1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015311.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 25 | 340 | 20 | 386 | |
| missense | 1 | 680 | 63 | 7 | 751 | |
| nonsense | 13 | 10 | 16 | 2 | 41 | |
| start loss | 1 | 1 | ||||
| frameshift | 22 | 25 | 17 | 1 | 65 | |
| splice donor/acceptor (+/-2bp) | 16 | 3 | 2 | 21 | ||
| Total | 36 | 53 | 741 | 408 | 27 | 1265 |
Highest pathogenic variant AF is 0.0003454124
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_056126.1 | 21 | MANE Select | |
| Ensembl | ENSP00000385636.1 | 21 | MANE Select | |
| RefSeq | NP_001166879.1 | 9 | Standard | |
| RefSeq | NP_001166902.1 | 14 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Post-translational protein modification
- Metabolism of proteins
- Neddylation
Biological Process
- microtubule cytoskeleton organization
- muscle contraction
- cytoskeleton organization
- Golgi organization
- regulation of mitotic nuclear division
Molecular Function
- protein binding
- cytoskeletal adaptor activity
- structural constituent of muscle
- actin filament binding
- muscle alpha-actinin binding
Cellular Component
- cytoplasm
- Golgi apparatus
- centrosome
- cytosol
- striated muscle thin filament
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000404537
- Coding exons
- 21
- Length
- 21131
- Individuals with no LoFs
- 123979
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 1160
- Defined
- 125141
- p
- 0.00465
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.00685 | 1170 | 1.17e+3 | 0.999 | 0.0000776 | 11872 |
| Missense (PolyPhen) | 427 | 426.77 | 1.0005 | 4414 | ||
| Synonymous | -0.193 | 517 | 511 | 1.01 | 0.0000347 | 4136 |
| Loss of Function | 2.42 | 51 | 73.4 | 0.695 | 0.00000410 | 750 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.010 | 0.0095 | notable |
| Latino/Admixed American | 0.0064 | 0.0063 | notable |
| Ashkenazi Jewish | 0.015 | 0.015 | notable |
| East Asian | 0.0028 | 0.0028 | notable |
| Finnish | 0.0042 | 0.0042 | notable |
| European (Non-Finnish) | 0.0037 | 0.0036 | notable |
| South Asian | 0.0016 | 0.0016 | notable |
| Other | 0.0067 | 0.0066 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Core component of the 3M complex, a complex required to regulate microtubule dynamics and genome integrity. It is unclear how the 3M complex regulates microtubules, it could act by controlling the level of a microtubule stabilizer (PubMed:24793695, PubMed:24793696). Acts as a regulator of the Cul7-RING(FBXW8) ubiquitin-protein ligase, playing a critical role in the ubiquitin ligase pathway that regulates Golgi morphogenesis and dendrite patterning in brain. Required to localize CUL7 to the Golgi apparatus in neurons. {ECO:0000269|PubMed:21572988, ECO:0000269|PubMed:24793695, ECO:0000269|PubMed:24793696}.;
Intolerance Scores
- LoFtool
- 0.861
- RVIS EVS
- -0.81
- RVIS percentile EVS
- 12.02
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.831
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | Medium | Medium |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |